Nectar Lifesciences Q1 Results
- BSE: 532649
- NSE: NECLIFE
- ISIN: INE023H01027
- Sector: Biotechnology & Drugs
BSE
12.13
0.31 (2.62%)
0.31 (2.62%)Volume1.36 L
Updated: Mon 13 Apr, 2026 | 10:38:49
NSE
12.150.40 (3.40%)
0.40 (3.40%)Volume7.85 L
Updated: Mon 13 Apr, 2026 | 10:23:48
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Nectar Lifesciences Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 359.08 | 600.77 | -40.23% | 334.96 | 7.20% |
| Depreciation/ Amortization | 16.52 | 15.77 | 4.75% | 15.46 | 6.83% |
| Operating Income | -78.41 | -,170.07 | -53.90% | 24.34 | 0.00% |
| Net Income | -63.23 | -,130.09 | -51.39% | 2.97 | 0.00% |
| Other Operating Expenses Total | 54.76 | 58.61 | -6.56% | 58.17 | -5.85% |
| Net Income Before Taxes | -96.75 | -,187.67 | -48.44% | 4.92 | 0.00% |
| Total Revenue | 280.67 | 430.70 | -34.83% | 359.30 | -21.88% |
| Selling/ General/ Admin Expenses Total | 24.26 | 23.81 | 1.92% | 23.99 | 1.15% |
| Diluted Normalized EPS | -2.82 | -5.84 | -51.72% | 0.13 | 0.00% |